Topors was identified recently as a human protein that binds to topoisomerase I and p53. Topors contains a highly conserved RING domain and localizes in promyelocytic leukemia nuclear bodies. Relatively little is known regarding topors expression patterns or function. We now demonstrate that topors mRNA and protein are widely expressed in normal human tissues. By contrast, topors mRNA and protein levels are decreased or undetectable in colon adenocarcinomas relative to normal colon tissue, and expression of the topors protein is not detectable in several colon cancer cell lines. The human TOPORS gene is located on chromosome 9p21, with loss of heterozygosity in this region frequently observed in several different malignancies. While we were unable to detect loss of heterozygosity of the TOPORS gene in 16 sporadic colon cancer cases, increased methylation of a CpG island in the TOPORS promoter was evident in colon adenocarcinoma specimens relative to matched normal tissues. Additional studies indicate that forced expression of topors inhibits cellular proliferation and is associated with an accumulation of cells in the G 0 /G 1 phase of the cell cycle. This effect is independent of the topors RING domain and maps to a C-terminal region of the protein. These results suggest that topors functions as a negative regulator of cell growth, and possibly as a tumor suppressor.
Introduction
Topors is a 1045-amino-acid protein that was originally discovered in a screen for proteins that bind to the Nterminus of topoisomerase I (Haluska et al., 1999) , and was also identified in a screen for proteins that interact with p53 (denoted p53BP3) (Zhou et al., 1999) . Furthermore, topors was identified in an assay for RING-domain proteins that are expressed in normal lung tissue (denoted LUN) (Chu et al., 2001) . Topors contains an N-terminal C3HC4-type RING domain, five PEST domains, and is rich in RS/SR dipeptides. The topors RING domain is conserved in orthologs from various species (Rasheed et al., 2002) and is closely related in sequence to the RING domains of known E3 ubiquitin ligases such as the herpesvirus protein ICP0 and Cbl (Boutell & Everett, 2003; Boutell et al., 2002; Joazeiro et al., 1999) . Indeed, in vitro and in vivo ubiquitination studies indicate that the topors RING domain confers an E3-type ubiquitin ligase activity (Rajendra et al., in preparation) .
Topors is also known to undergo modification by the small ubiquitin-like modifier SUM0-1 (Weger et al., 2003) , and to associate with promyelocytic leukemia (PML) nuclear bodies in the nuclei of exponentially growing cells (Rasheed et al., 2002; Weger et al., 2003) . Treatment with transcriptional inhibitors or with the topoisomerase I-targeting drug camptothecin results in rapid dispersion of topors to the nucleoplasm, suggesting that topors is involved in the cellular response to transcriptional perturbation (Rasheed et al., 2002) . However, mutagenesis studies indicate that the topors RING domain is not required for colocalization with PML nuclear bodies (Rasheed et al., 2002) .
To gain insight into the function of topors, we studied the expression of topors mRNA and protein in human tissues and cell lines. While topors mRNA and protein are readily detected in normal tissues, expression is commonly diminished or undetectable in colon cancer cell lines and in clinical colon adenocarcinoma specimens. Furthermore, loss of topors expression in colon cancer cells may relate to promoter hypermethylation, since we observed methylation of a CpG island in the TOPORS promoter in colon adenocarcinoma specimens, but not in adjacent normal colon tissues. Taken together with the finding that forced expression of topors inhibits cellular proliferation and induces arrest in the G 0 /G 1 phase of the cell cycle, these results suggest that topors may function as a tumor suppressor.
Results

Differential expression of TOPORS mRNA and protein in normal versus malignant human tissues
Initial analyses of topors expression in HeLa and U-937 cells indicated low to undetectable levels of expression of both topors mRNA and protein in these cell lines (Haluska et al., 1999; Rasheed et al., 2002 and data not shown). To further investigate this finding, topors mRNA expression was analysed in a panel of normal human tissues using b-actin-normalized cDNAs and semiquantitative RT-PCR. The results indicate that topors mRNA expression is readily detected in most normal human tissues, although using our primers and PCR conditions, expression levels are low compared to b-actin (Figure 1a ). In this panel of normal tissues, topors mRNA expression was greatest in the testis, placenta, and pancreas ( Figure 1a ). We also evaluated topors protein expression in normal human tissues using a topors polyclonal antibody. The results indicate that the topors protein is present in whole-cell lysates obtained from a variety of normal human tissues, including colon, lung, kidney, and uterine tissues ( Figure 1b) .
Next, using a multiplex RT-PCR assay, we analysed topors mRNA levels in a series of normal and malignant colon tissues, since colon cancer is a common disease and matched specimens (tumor and normal tissue obtained from the surgical specimen of a single patient) are readily available. Whereas G3PDH mRNA levels were similar in matched malignant and normal colon tissues, topors mRNA levels were decreased or undetectable in five of six colon adenocarcinoma specimens compared to adjacent normal tissues (Figure 2a) . By contrast, topors mRNA levels were similar in a benign adenoma specimen compared to adjacent normal colon tissue (Figure 2a, 1545 N and T) .
We also investigated topors protein expression in a series of normal and malignant colon cancer specimens. When the samples were normalized for b-actin protein levels, topors protein expression was detected in 100% of lysates from normal colon specimens (n ¼ 8), and in a tissues was subjected to multiplex RT-PCR using topors-specific and G3PDH-specific primers. PCR products were visualized using agarose gel electrophoresis, followed by ethidium bromide staining. Migration of the 264 bp topors and the 982 bp G3PDH PCR products is indicated. The numbers at the top of each panel refer to a matched specimen number. Note that in specimen 1545 the tumor is a benign adenoma rather than an adenocarcinoma, which is the case for all other tumor specimens. (Figure 2b ). By contrast, topors protein expression was not detectable in any of seven colon adenocarcinoma specimens (Figure 2b) . Furthermore, the relative decrease in topors protein expression in malignant versus normal colon tissues is likely underestimated using this technique, since Ponceau staining indicated that b-actin normalization typically results in significantly more protein being loaded in the malignant tissue lanes relative to normal tissue lanes ( Figure 2b) . As an additional control for nuclear protein extraction, we also evaluated topoisomerase I protein levels in the normal and malignant tissue specimens. In contrast to topors, but as reported previously (Giovanella et al., 1989) , topoisomerase I expression was greater in malignant colon tissues compared to normal colon tissues ( Figure 2b , right panel). Notably, in two cases, there was sufficient tissue for analyses of both topors protein and mRNA expression in the same specimen. Topors protein and mRNA expression were detectable in both the normal and tumor (benign adenoma) tissues in one case (denoted as 1545N and T in Figure 2a , and as a single asterisk in Figure 2b ), whereas in the other case, both topors protein and mRNA expression were evident only in the normal tissue (132N and T in Figure 2a , and double asterisk in Figure 2b ). Thus, for these two cases, there was a correlation between topors protein and mRNA expression levels. Additional studies indicated that the topors protein was not detectable in whole-cell lysates obtained from several different colon cancer cell lines (Figure 3) . Furthermore, the topors protein remained undetectable in lysates obtained from these cell lines after they were growth-arrested as a result of serum starvation (growth for 1, 2, or 3 days in 0.2% serum), suggesting that loss of topors protein expression in these cells is not related to their proliferative state (data not shown). Since topors contains several PEST domains, we also investigated whether the low levels of topors protein expression in these cell lines might relate to constitutive proteasomemediated degradation. However, whereas treatment with the proteasome inhibitors PS-341 or lactacystin was sufficient to increase levels of the constitutively degraded p21 protein in HT29 cells, this treatment did not increase topors protein levels (data not shown), suggesting that the inability to detect the topors protein in colon cancer cell lines is not related to constitutive proteasome-mediated degradation.
Analyses of the TOPORS gene in normal and malignant colon tissues
We evaluated methylation of the TOPORS promoter to explore possible mechanisms underlying the frequent loss of topors RNA expression in colon cancer tissues. Analysis of the TOPORS promoter region using the MethPrimer algorithm (Li and Dahiya, 2002) identified a CpG island encompassing bases À1052 to À859 (where position 1 represents the translation start site). We examined methylation of CpGs in this region in matched normal and malignant colon tissues using a methylation-specific PCR assay. CpG methylation in this region was not detectable in six normal colon specimens ( Figure 4 ). By contrast, methylation of this region was evident in three of the six colon adenocarcinoma specimens (Figure 4) , suggesting that at least in some cases, loss of topors mRNA expression in colon cancers is the result of transcriptional silencing due to promoter methylation.
We also investigated loss of heterozygosity (LOH) of the TOPORS gene in colon adenocarcinoma specimens. Methylation of the TOPORS promoter in colon cancer tissues. DNA obtained from matched normal (N) and malignant (T) colon tissues was treated with bisulfite, followed by methylation-specific PCR as indicated in Materials and methods. PCR primers were designed to amplify a CpG island in the TOPORS promoter, encompassing bases À1052 to -859, where position 1 indicates the translation start site. M and U represent primers specific for methylated and unmethylated DNA, respectively Differential expression of topors in normal and malignant tissues A Saleem et al TOPORS was identified within contig AL353671 in the Sanger chromosome 9 sequencing effort and is currently mapped to the 9p21 region. The TOPORS coding sequence is contained in three exons, with the first exon encoding only the initiation methionine, whereas the second exon encodes residues 2-66. The remainder of the coding sequence is encoded in exon 3, including the highly conserved RING domain. LOH in the chromosome 9p21 region has been described for several different malignancies, in many but not all cases related to loss of the tumor suppressor gene p16/CDKN2 (Kamb et al., 1994; Nobori et al., 1994; Puig et al., 1995; Devlin et al., 1996; Kim et al., 1997; Perinchery et al., 1999; Pollock et al., 2001) . To evaluate LOH of the TOPORS gene, matched pairs of normal and cancer tissue specimens from 16 colon cancer patients were analysed using single-nucleotide polymorphism (SNP) markers that spanned a 120-kb region. For the 11 markers used in the study, one of the markers was not informative and the other 10 markers were heterozygous for 4-10 patients each. For all informative loci in the corresponding patients, no LOH was identified, suggesting that deletion of the TOPORS gene is infrequent in sporadic colon cancer.
Forced expression of topors inhibits cellular proliferation by inducing cell cycle arrest in a ring-independent manner
To further investigate the relative lack of topors mRNA and protein expression in cancer tissues and cell lines, we analysed the effects of overexpression of topors on cellular proliferation using transient transfections and a thymidine incorporation assay. The results indicate that transfection of HeLa cells with a GFP-topors expression construct is associated with an approximately 45% decrease in thymidine incorporation compared to transfection with a GFP vector alone ( Figure 5 ). It is likely that these results underestimate the antiproliferative effects of topors overexpression, since as assayed by fluorescent microscopy, typical transfection efficiencies are 50% or less in these cells using the GFP-topors plasmid.
To determine whether the highly conserved topors RING domain is required for antiproliferative activity, similar experiments were performed using a vector expressing a RING-less topors fragment (231-1045). Transfection of HeLa cells with the RING-less topors vector yielded results similar to those obtained with the full-length construct ( Figure 5) . Therefore, the topors RING domain is dispensable for the antiproliferative effects associated with forced expression of this protein. Similar antiproliferative activity was observed with a topors fragment (539-1045) that included deletion of a larger N-terminal region ( Figure 5 ). Additional mapping studies indicated that residues within a 540-704 region are both necessary and sufficient for antiproliferative activity, since overexpression of 705-1045 or 1-539 fragments had minimal effects on cell growth, whereas overexpression of a 540-704 fragment yielded antiproliferative effects that were similar to those observed with the full-length protein ( Figure 5) . Notably, the lack of effect of the 704-1045 and 1-539 fragments is not due to poor expression or protein instability, since as reported previously (Rasheed et al., 2002) , expression levels for these GFP fusion proteins were similar to that of fulllength GFP-topors in HeLa cells ( Figure 5 ).
To further characterize the antiproliferative effects of topors, we studied the cell cycle distribution of GFPtopors transfectants using propidium iodine staining and flow cytometry. The results indicate that overexpression of topors is associated with accumulation of cells in the G 0 /G 1 phase of the cell cycle, demonstrating that the antiproliferative effects of topors relate to inhibition of transition from G 0 /G 1 to the S phase of the cell cycle rather than induction of apoptosis ( Figure 6 ). Consistent with the thymidine incorporation studies, this effect does not require the topors RING domain, since a 231-1045 fragment yielded results similar to 
Discussion
This report is the first detailed description of topors mRNA expression in both normal and malignant human tissues, and is the first description of expression of the topors protein in these tissues. Our finding that topors mRNA is widely expressed in normal human tissues is consistent with previous reports (Zhou et al., 1999; Chu et al., 2001) . Furthermore, similar to Zhou et al. (1999) , we observed high levels of topors mRNA in the testis. By contrast, we observed that topors mRNA levels are commonly decreased or undetectable in human colon adenocarcinomas. Similar results were obtained in analyses of topors protein expression, which indicated relatively widespread expression in normal human tissues, but decreased or absent expression in both colon adenocarcinoma specimens and cell lines. We also investigated mechanisms underlying the loss of topors expression in colon adenocarcinomas. Our results implicate promoter hypermethylation as at least one such mechanism. Notably, hypermethylation of the promoter region of the p16/CDKN2 tumor suppressor gene, which is located near TOPORS on chromosome 9p21, is involved in the decreased expression of p16/ CDKN2 in a variety of cancers Merlo et al., 1995; Nuovo et al., 1999) . Therefore, it is possible that in some cancers the occurrence of aberrant DNA methylation on 9p21 may concurrently silence both p16/CDKN2 and TOPORS. In addition to promoter hypermethylation, LOH in cancer specimens is commonly observed for tumor suppressor genes. Although we were unable to identify LOH of TOPORS in 16 sporadic cases of colon cancer, given the data implicating tumor suppressor gene(s) in addition to p16/ CDKN2 in the 9p21 chromosomal region in multiple cancers (Puig et al., 1995; Kim et al., 1997; Waber et al., 1997; Wiest et al., 1997; Pollock et al., 2001; Schraml et al., 2001) , studies of LOH of the TOPORS gene in other cancers are warranted.
Consistent with the finding that topors expression is reduced in malignant tissues and cell lines, our results indicate that forced expression of topors inhibits cellular proliferation. Flow cytometric studies indicate that the antiproliferative effects of topors relate to induction of cell cycle arrest in the G 0 /G 1 phase of the cell cycle rather than induction of apoptosis. The mechanisms underlying the induction of cell cycle arrest by topors are not yet known. Notably, while the topors RING domain confers a ubiquitin ligase activity (Rajendra et al., in preparation), our mapping studies demonstrate that the RING domain is dispensable for induction of cell cycle arrest. This finding indicates that direct ubiquitination of topoisomerase I, p53, or other substrates by topors cannot be responsible for the antiproliferative effects observed with overexpression of this protein. Our current results implicate the 540-704 region of topors as sufficient for antiproliferative activity. While there are no recognizable functional motifs in this region, previous studies indicate that the 540-704 region is required for the association of topors with PML nuclear bodies (Rasheed et al., 2002) . Notably, perturbation of PML nuclear bodies is implicated in carcinogenesis (Dyck et al., 1994) , and overexpression of PML induces cell cycle arrest in the G 0 /G 1 phase of the cell cycle (He et al., 2003) . Therefore, the antiproliferative effects of topors may relate to a ubiquitin-independent function in PML nuclear bodies. 
Materials and methods
Topors mRNA analyses
Expression of topors mRNA in normal human tissues was analysed using the Human Rapid-Scan Gene Expression Panel (Origene Technologies Inc., Rockville, MD, USA). This panel consists of serially (fourfold) diluted, first-strand cDNAs from 24 different human tissues in a 96-well plate format, with the cDNA concentrations normalized to b-actin levels. Semiquantitative PCR was performed using Titanium Taq polymerase (Clontech Laboratories Inc., Palo Alto, CA, USA). Topors primers spanned intron 2 (exon 2 primer CTGCTCCCGCTCGGAGGGTAGCGGAGAA and exon 3 primer TCCAAGCATATAGGACACTTAGAATCA). b-Actin-specific primers were provided with the Origene kit. Thermocycling included an initial denaturing step at 941C for 90 s followed by 33 cycles through the following steps: 941C for 30 s, 651C for 30 s, and 681C for 1 min. A final extension step was then carried out at 681C for 2 min. PCR products were resolved and visualized using agarose gel electrophoresis and ethidium bromide staining. Optimization of PCR conditions to ensure linearity of the PCR products with respect to input cDNA quantity was performed initially using two of the 24 human tissue cDNAs (salivary gland and colon tissues), so these tissues are not included in the results. Serial dilutions over a 4-log range were used to establish that the resulting band intensities were linear with respect to input cDNA.
Topors mRNA expression was also analysed in malignant and normal human tissues that were obtained from the Cancer Institute of New Jersey (CINJ) Tissue Retrieval Service or the Cooperative Human Tissue Network (http://www.chtn.ims.nci.nih.gov/) without personal identifying information, under the approval of the Robert Wood Johnson Medical School Institutional Review Board. CINJ tissues were snap-frozen within 30 min of surgical removal using liquid nitrogen and methyl butane. Tissue histology was reconfirmed by hematoxylin and eosin staining. After thawing on ice, frozen tissue specimens were weighed and cut into approximately 0.1 g aliquots. While maintaining the tissue on ice at all times, the tissue was sliced into small pieces using a small surgical blade that was treated with RNase inhibitor, followed by homogenization using a Tissue Tearor Homogenizer (Biospecs Products Inc., Racine WI, USA). Total RNA was isolated using the Gentra PUREscript RNA Isolation Kit (Gentra Systems Inc., Minneapolis, MN, USA). Semiquantitive multiplex RT-PCR was performed using a single-tube RT-PCR method (Clontech Advantage One Step RT-PCR). Random hexamers were used for the cDNA synthesis step, and both TOPORS primers (listed above) and G3PDH primers (upstream TGAAGGTCGGAGTCAACGGATTTGGT and downstream CATGTGGGCCATGAGGTCCACCAC) were included in each tube. PCR conditions were optimized to ensure that both PCR products were linearly related to the amount of input RNA. The samples were subjected to an initial RT step at 501C for 1 h, followed by heat activation of the Taq polymerase at 941C for 5 min. Samples were then cycled 34 times through the following steps: 941C for 30 s, 651C for 30 s, and 681C for 1 min. A final extension step was then carried out at 681C for 2 min. PCR products were analysed using agarose gel electrophoresis and ethidium bromide staining.
Topors protein analyses
HCT15, HCT116, HT29, and RKO colon cancer cell lines were obtained from ATCC (Manassas, VA, USA) and maintained using recommended culture conditions. For immunoblotting analyses, exponentially growing cells were lysed using SDS sample buffer, followed by polyacrylamide gel electrophoresis. Immunoblotting was performed using a topors polyclonal antibody and a chemiluminescent technique as described (Rasheed et al., 2002) .
For analysis of topors protein expression in human normal and malignant tissue, approximately 0.1 g of tissue was cut into small pieces and homogenized in five volumes of buffer containing 50 mM Tris-Cl pH 7.2, 150 mM NaCl, 1 mM PMSF, 0.5 mg/ml leupeptin, and 1 mg/ml pepstatin. SDS was then added to 1%, and the lysates were incubated at 951C for 10 min, then centrifuged at 13 000 g for 10 min. The supernatants were analysed using SDS-polyacrylamide gel electrophoresis and immunoblotting. For comparison of topors protein expression in normal and malignant tissues, tissue lysates were first analysed for b-actin expression using a monoclonal actin antibody (Amersham Life Sciences). Samples were normalized for b-actin expression and then subjected to immunoblotting using either topors or topoisomerase I (Chang et al., 1992) antibodies.
DNA methylation studies
DNA was obtained from approximately 0.1 g of homogenized matched normal and cancer tissue specimens using proteinase K and RNase A treatment, followed by isopropanol-based DNA precipitation (Gentra PUREgene DNA Purification Kit). The DNA was treated with sodium bisulfite to convert unmethylated cytosines to uracil based on a previously described method (Frommer et al., 1992) . Briefly, about 2 mg of DNA was denatured in freshly prepared 0.2 M sodium hydroxide for 10 min at 371C. Freshly prepared solutions of hydroquinone (Sigma) and sodium bisulfite (Sigma) were added to each tube at final concentrations of 3.5 mM and 2.6 M, respectively. The samples were layered with mineral oil and incubated for 16 h at 501C. The DNA was then purified using Wizard DNA Clean-Up columns (Promega), followed by ethanol precipitation. A positive methylation control was generated by treating 1 mg of normal colon tissue DNA with CpG methylase (New England Biolabs) for 1 h at 371C prior to bisulfite treatment. A negative control was generated using PCR to amplify a TOPORS DNA fragment from normal colon DNA. The resulting 254 bp PCR fragment was gelpurified and subsequently treated with bisulfite as described above.
Methylation-specific PCR (MSP) was performed using primer sequences designed by the MethPrimer algorithm (Li and Dahiya, 2002) . Two primer sets were utilized, corresponding to methylated and unmethylated sequences for a CpG island identified near the TOPORS translation start site. Methylated: left TAATTTTAGTATTTTGGGAGGTCGA, right CTTCTAAATTCACACCAATCTCGTA; unmethylated: left TAATTTTAGTATTTTGGGAGGTTGA, right CTTCTAAATTCACACCAATCTCATA. MSP conditions were optimized using the positive and negative controls described above. MSP was performed in a buffer containing 16.6 mM ammonium sulfate, 67 mM Tris-Cl pH 8.8, 6.7 mM MgCl 2 , and 10 mM b-mercaptoethanol. Reactions contained 2 ml of bisulfite-treated DNA. Thermocycling was performed using a Biometra T-Gradient PCR machine, involving an initial 5 min denaturation step at 951C. A measure of 1.25 U of Taq polymerase (Invitrogen) diluted in 10 ml of sterile water was then added to each tube. Thermocycling continued with 30 cycles of the following steps: 30 s at 951C, 30 s at a temperature specific for each primer set (58.21C for methylated DNA primers, 59.41C for unmethylated DNA primers), and then 30 s Differential expression of topors in normal and malignant tissues A Saleem et al at 721C. The reaction was completed by incubation at 721C for 4 min. Reaction products were visualized using 3% agarose gels stained with ethidium bromide.
Loss-of-heterozygosity studies
In all, 11 SNP markers were selected in the region of the TOPORS gene, using the dbSNP database and MapView (National Center for Biotechnology Information). These markers span a 120-kb region with one of them located in intron 2 of the TOPORS gene (Table 1) . Three primers were designed for each SNP, including one pair of regular PCR primers and one primer that converts the polymorphism site of the SNP into a desired restriction fragment length polymorphism during PCR, using a previously described method (Li and Hood, 1995) . All the PCR primers were selected manually to avoid any unexpected interactions between primers.
A laser-capture microdissector (Leica DM Lmd, Leica, Germany) was used to obtain DNA from tissue specimens. Sections (15 mm) cut from paraffin-embedded normal and cancer tissue blocks were used for microdissection. DNA was released from the microdissected material as described previously (Cui et al., 2000) . Briefly, 3 ml of lysis buffer (200 mM KOH and 50 mM dithiothreitol) was added to the microdissected specimens. After 10 min incubation at 651C, the lysate was neutralized with 3 ml of neutralization buffer (200 mM HCl, 900 mM Tris-HCl, pH 8.3, and 300 mM KCl).
The polymorphic sequences of the SNPs were amplified in two PCR rounds. In the first round, 11 loci were simultaneously amplified in a total volume of 30 ml. The reaction consisted of 40 nM of each primer, 100 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 100 mg/ml gelatin, 200 mM each dNTP, and 1 U Taq DNA polymerase. An initial denaturation step at 941C for 15 min was followed by 40 cycles of 941C for 40 s, 551C for 2 min, and ramping from 55 to 701C within 5 min. At the end of PCR, an incubation step was included at 721C for 3 min to minimize the amount of incompletely extended DNA strands.
The converting primer and one of the regular PCR primers for each locus were used in the second round of PCR. The 11 loci were subdivided into two groups according to the restriction enzymes needed for genotyping. After 100-fold dilution in water, 1 ml aliquots of the first-round products were reamplified separately in the two groups with the same PCR conditions described above but using a different primer concentration (0.15 mM for each primer) and only 25 cycles.
The second-round PCR products from the two groups were digested by the restriction enzymes DdeI and NlaIII, respectively, for 1 h at 371C. The resulting fragments were resolved by electrophoresis with 8% polyacrylamide gels, stained with ethidium bromide, and visualized and photographed under UV illumination. Using this technique, the genotype for each SNP is identified by a characteristic migration pattern on the gels.
Thymidine incorporation studies
HeLa cells growing exponentially in six-well tissue culture plates were transfected with 5 mg of either pEGFP, pEGFPtopors, or various plasmids expressing GFP-topors deletion mutants using Lipofectamine Plus (Gibco BRL) as described previously (Rasheed et al., 2002) . Plasmids expressing GFP fusions to residues 231-1045, 539-1045, 704-1045, 1-539, and 1-704 of topors have been described (Rasheed et al., 2002) . A mammalian expression plasmid encoding fusion of GFP to the N-terminus of a 540-704 topors fragment was constructed by digestion of pEGFP-topors 530-1045 with KpnI, followed by Mung bean nuclease and AccI digestion. The resulting 5.2 kb fragment was isolated, treated with Klenow enzyme, and ligated. Sequencing confirmed that the correct recombinant had been obtained.
Incorporation of 3 H-thymidine into DNA was analysed using a previously published method (Narla et al., 2001) . Briefly, 16 h after transfection, 1 mCi/ml of 3 H-thymidine was added to the media. After an additional 24 h, cells were washed four times with ice-cold PBS and fixed in methanol for 30 min at 41C. After removal of methanol and drying, the cells were solubilized in a solution of 0.25% NaOH and 0.25% SDS. The lysates were neutralized with 1 N hydrochloric acid, and radioactivity was quantified by liquid scintillation counting.
Flow cytometry
As described above, HeLa cells growing exponentially in 60 mm tissue culture plates were transiently transfected with 2.5 mg of either pEGFP-topors, or plasmids expressing GFPtagged topors deletion mutants. The pEGFP-F plasmid (Clontech), which expresses farnesylated GFP, was used as a control to assess the effects of expression of GFP alone. The farnesylation signal directs GFP to the inner face of plasma membrane to prevent leakage from ethanol-permeabilized cells.
At 24 h after transfection, cells were processed for flow cytometric analyses using ethanol fixation and propidium Table 1 List of primers for loss-of-heterozygosity studies. Left and right primers used to amplify regions near the TOPORS lows are indicated by L or R suffix; primers used to convert a SNP into a desired restriction enzyme sequence are noted by a CPD suffix.
Asterisks indicate primers for a SNP in intron 2 of TOPORS   39M008L  TGGGCTTAGGAACAGAATGAACT  39M008R  TTCTGAAGTACTGGGGTTTAGGAC  CPD008L  AGGTGACAAGATAGGTTGCTGTTC  19M009L  TAAGGAGACTGAGAAAGCAGAGAA  19M009R  GCACCAACAATGCAGACAAAACT  CPD009L  GAGAAGCTGAGGTTTGACATCT  39M015L  GGATGATGTGCCATGTATTGTT  39M015R  AGTAAGCTCAGACATTGAGAAATTG  CPD015R  CTATAGTTGATCAAGAAATACACAC  29M018L  AGTGTTTCTGTGTAGAAACTGGAAG  29M018R  CAGATTGTCTCTGCGCACTCA  CPD018l  CTGAACCCTGCTCCTGCTCA  39M028L  CTTGGTTGGGCAGAGTTGAGAGT  39M028R  AAGGCAGGAACCAAAGAAGGC  CPD028R  ACATTCACCACTGCCATCCT  39M029L  AACCAGGAAGGGATTTGTGGAG  39M029R  ACTCTGTGGGTCCTGGAGGAG  CPD029l  TTTGTGGAGGTACAAATATAGAATC  39M006L  CTATTAATCCCAATTTCCTTCCTGA  39M006R  GCTCCCTTTTGTCATTTACACAAAG  CPN006l  TTTTATTATGGCATATTATGCAACA  19M010L  AGACCTCAAGGGTATCTTTCAC  19M010R  ACATGTCAATTCTCCCTATGCTA  CPN010R  GAAAGTAAGTTAAAAGAAAAAGCAT  *29M016L  TCTGGACCCATATAATCAGTTATGG  *29M016R  GTGTGACGGGACATATTTCATAA  CPN016r  ACTCAACAATGTTCTCTATGTTACA  29M025L  CAGTAGTTACCCAGGTCTTGCAGA  29M025R  GAAACTCATGAGGCTGAGTTGAAT  CPN025l  AGACTATCTGAATTTGTGAGTCCAT  19M026L  GACTTTGAACACACTGGAACATTA  19M026R  TTATTACTATCGCAACTTGGAGG  CPN026r GAAGCAGATCAGCTCTTCAAAACC Differential expression of topors in normal and malignant tissues A Saleem et al iodide staining. Briefly, cells were removed from culture plates using trypsin/EDTA and a single-cell suspension was generated by gentle pipetting. Cells were pelleted and resuspended in 300 ml of ice-cold PBS. While gently vortexing, ice-cold 70% ethanol was added and the tubes were placed on ice for 30 min. The cells were washed with ice-cold PBS and then incubated with 50 ml of 1 mg/ml RNAse A (Sigma) and 5 ml of 1 mg/ml propidium iodide (Sigma) at room temperature for 30 min. The cell samples were analysed using a Beckman Coulter flow cytometer (FC500) and RXP acquisition and analysis software. For determination of cell cycle distribution in transfectants expressing GFP or GFP-topors fusion proteins, cells were analysed simultaneously for GFP and propidium iodide fluorescence.
